Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
重症急性呼吸器症候群関連コロナウイルスを標的とする干渉ＲＮＡＳ、及びＣＯＶＩＤ－１９を治療するためのそれらの使用
Document Type and Number:
Japanese Patent JP2023553610
Kind Code:
A
Abstract:
ＳＡＲＳ－ＣｏＶ（例えば、そのＰＯＬ、スパイク、ヘリカーゼ、又はエンベロープ遺伝子）を標的とする干渉ＲＮＡ（例えば、ｓｉＲＮＡ）、及びＳＡＲＳ－ＣｏＶ感染を阻害しかつ／又はその感染に関連する疾患（例えば、ＣＯＶＩＤ－１９）を治療するためのそれらの治療的使用が提供される。【選択図】

More Like This:
JP2990268INDUSTRIAL APPLICABILITY: Expression system for functional nucleic acid transcription
JP6027893Medical treatment of the sex hormone joint globulin (SHBG) associated diseases by prevention of the natural antisense transcript to sex hormone joint globulin (SHBG)
WO/2021/022229POPULATIONS OF NATURAL KILLER CELLS COMPRISING A CLEAVAGE RESISTANT CD16
Inventors:
Chang, Yi-Chun
Yang, Qi-fan
Chen, Yi-Feng
Yang, Cha-Chun
Chou, Yuan-Ling
Application Number:
JP2023534695A
Publication Date:
December 25, 2023
Filing Date:
December 03, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Microbio (Shanghai) Company Limited
International Classes:
C12N15/113; A61K31/573; A61K31/661; A61K31/713; A61K39/215; A61K39/395; A61K45/00; A61K48/00; A61P31/14; A61P43/00
Attorney, Agent or Firm:
Ryoichi Takaoka
Nao Oda
Akiyo Iwahori
Rena Miyoshi
Kamoto Takahashi



 
Previous Patent: How to determine the likelihood that a subject will respond to lipid-lowering therapy

Next Patent: Ultrasonic sensor assembly for automobiles, and automobiles